SecBot SecBot

CELG-RI

BRISTOL MYERS SQUIBB CO
NYSE· Pharmaceutical Preparations· Inc. DE· CIK 0000014272 Biotech & Drug Discovery
Rights of BRISTOL MYERS SQUIBB CO · BMY stock page →
—
Filing reports
2
analyzed by SecBot
SecBot read MIXED 2 reports · latest
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest NEUTRAL Bristol-Myers Squibb Company is terminating registration for certain securities under Section 12(g) of the…
All reports →

Price

Daily candles with volume.

Washington

Corporate Lobbying

89 lobbying filings and 10 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Apr 17, 2025
FDA
ELIQUIS
Original Approval — Type 3 - New Dosage Form — SUSPENSION
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Apr 17, 2026 SEC
Bristol Myers Squibb is holding its 2026 annual meeting where shareholders will vote on director elections, executive…
DEFA14A — Impact 3/10
Mar 27, 2026 SEC
Bristol-Myers Squibb Company is terminating registration for certain securities under Section 12(g) of the Exchange…
15-12G — Impact 6/10
Apr 17, 2025 Event
ELIQUIS
Original Approval — Type 3 - New Dosage Form — SUSPENSION

SecBot reports

2 filings · 0 bullish · 0 bearish · 2 neutral
All CELG-RI filing & press-release reports (2)